Molecule Details
InChIKeyMUOKSQABCJCOPU-UHFFFAOYSA-N
Compound NameSilmitasertib
Canonical SMILESO=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)36
Pfam Stratification Cross-Family
Avg pChEMBL7.54
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB15408
Drug NameSilmitasertib
CAS Number1009820-21-6
Groups investigational
ATC Codes nan
DescriptionSilmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery).

Categories: Casein Kinase II, antagonists & inhibitors Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 50335638 CHEMBL1230165 ChemSpider: 25057795 PDB: 3NG Wikipedia: Silmitasertib ZINC: ZINC000058638454
Target Activities (36)
Target Gene Organism Category Pfam pChEMBL Type Source
P67870 CSNK2B Homo sapiens Human PF01214 8.8 IC50 ChEMBL
P19784 CSNK2A2 Homo sapiens Human PF00069 8.6 IC50 ChEMBL;BindingDB
Q8NEV1 CSNK2A3 Homo sapiens Human PF00069 8.6 IC50 ChEMBL;BindingDB
P68400 CSNK2A1 Homo sapiens Human PF00069 8.6 IC50 ChEMBL;BindingDB
P48729 CSNK1A1 Homo sapiens Human PF00069 8.4 IC50 ChEMBL;BindingDB
P48730 CSNK1D Homo sapiens Human PF00069 8.4 IC50 ChEMBL
P49674 CSNK1E Homo sapiens Human PF00069 8.4 IC50 ChEMBL
P49760 CLK2 Homo sapiens Human PF00069 8.4 IC50 ChEMBL;BindingDB
P78368 CSNK1G2 Homo sapiens Human PF12605 PF00069 8.4 IC50 ChEMBL
Q9HCP0 CSNK1G1 Homo sapiens Human PF12605 PF00069 8.4 IC50 ChEMBL
Q9Y463 DYRK1B Homo sapiens Human PF00069 8.2 IC50 ChEMBL;BindingDB
Q13627 DYRK1A Homo sapiens Human PF00069 8.2 IC50 ChEMBL;BindingDB
P49759 CLK1 Homo sapiens Human PF00069 8.0 IC50 ChEMBL;BindingDB
Q9HAZ1 CLK4 Homo sapiens Human PF00069 8.0 IC50 ChEMBL;BindingDB
O43293 DAPK3 Homo sapiens Human PF00069 7.8 IC50 ChEMBL;BindingDB
Q16644 MAPKAPK3 Homo sapiens Human PF00069 7.6 Kd ChEMBL
O43781 DYRK3 Homo sapiens Human PF00069 7.5 IC50 ChEMBL
P36888 FLT3 Homo sapiens Human PF00047 PF07714 7.5 IC50 ChEMBL;BindingDB
Q9UHD2 TBK1 Homo sapiens Human PF00069 PF18394 PF18396 7.5 IC50 ChEMBL;BindingDB
P49761 CLK3 Homo sapiens Human PF00069 7.4 IC50 ChEMBL;BindingDB
Q9H422 HIPK3 Homo sapiens Human PF00069 7.3 IC50 ChEMBL;BindingDB
P11309 PIM1 Homo sapiens Human PF00069 7.3 IC50 ChEMBL;BindingDB
O95067 CCNB2 Homo sapiens Human PF02984 PF00134 7.2 IC50 ChEMBL
P06493 CDK1 Homo sapiens Human PF00069 7.2 IC50 ChEMBL;BindingDB
P14635 CCNB1 Homo sapiens Human PF02984 PF00134 7.2 IC50 ChEMBL
Q8WWL7 CCNB3 Homo sapiens Human PF02984 PF00134 7.2 IC50 ChEMBL
O94804 STK10 Homo sapiens Human PF00069 PF12474 7.0 Kd ChEMBL
Q92630 DYRK2 Homo sapiens Human PF00069 7.0 IC50 ChEMBL
Q9P1W9 PIM2 Homo sapiens Human PF00069 6.7 IC50 ChEMBL;BindingDB
P49841 GSK3B Homo sapiens Human PF00069 6.7 Kd ChEMBL
Q9H2G2 SLK Homo sapiens Human PF00069 PF12474 6.7 Kd ChEMBL
Q9UGJ0 PRKAG2 Homo sapiens Human PF00571 6.5 Kd ChEMBL
Q00535 CDK5 Homo sapiens Human PF00069 6.3 Kd ChEMBL
P53350 PLK1 Homo sapiens Human PF00069 PF00659 6.2 Kd ChEMBL
Q9UPZ9 CILK1 Homo sapiens Human PF00069 6.0 Kd ChEMBL
Q08499 PDE4D Homo sapiens Human PF18100 PF00233 6.0 IC50 ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P68400 CSNK2A1 Casein kinase II subunit alpha inhibitor targets